Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 24, 2017JAMA DermatologyOpen Access

Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

View Full Paper
Ask AI
Bookmark
Share

Authors

SZStefanie ZimmermannPSPeggy SekulaMVMoritz Venhoff

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zimmermann et al. (2017) studied this question.

synapsesocial.com/papers/69df2b71d85e58e37b7a198fhttps://doi.org/10.1001/jamadermatol.2016.5668
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: A multicentric retrospective study2011 · 119 citations
  2. 2Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis2015 · 43 citations
  3. 3Toxic epidermal necrolysis: a study of 22 cases1994 · 15 citations
  4. 4The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies2007 · 22,390 citations